Dysbiosis of intestinal microbiota to predict in-hospital mortality in critically ill patients: results of a prospective observational cohort study

Abstract

Background: Despite the essential functions of the intestinal microbiota in human physiology, little research has been reported on the gut microbiota alteration in intensive care patients. This investigation aimed to explore the dysbacteriosis of intestinal flora in critically ill patients, and evaluate the prognostic performance of this dysbiosis to predict in-hospital mortality. Methods: A prospective cohort of patients were consecutively recruited at Intensive Care Units (ICUs) in Guangdong Provincial People's Hospital from March 2017 through October 2017. Acute Physiology and Chronic Health Evaluation (APACHE) II score and Sequential Organ Failure Assessment (SOFA) score were assessed, and fecal samples were taken for examination within 24 hours of ICU admission. The taxonomic composition of intestinal microbiome was determined using 16S rDNA gene sequencing. Patients were divided into survival and death group based on the outcomes in hospital. The two groups were statistically compared using the independent samples t test and Metastats analysis. Genera of bacteria showing significantly different abundance between groups were assessed for predictors of in-hospital death. The prognostic value of bacterial abundance alone and in combination with APACHE II or SOFA score were evaluated using the area under the receiver operating characteristic curve (AUROC). Results: Among the 61 patients that were examined, a total of 12 patients (19.7%) died during hospital stay. Bifidobacterium differed significantly in abundance between survival and death group ( P =0.031). The AUROC of Bifidobacterium abundance identifying in-hospital death at a cut-off probability of 0.0041 was 0.718 (95% confidence interval [CI], 0.588-0.826). The panel of Bifidobacterium abundance plus SOFA (AUROC, 0.882; 95% CI, 0.774-0.950) outperformed SOFA (AUROC, 0.649; 95% CI, 0.516-0.767; P =0.012) and Bifidobacterium abundance alone ( P =0.007). The panel of Bifidobacterium abundance plus APACHE II (AUROC, 0.876; 95% CI, 0.766-0.946) outperformed APACHE II (AUROC, 0.724; 95% CI, 0.595-0.831; P =0.035) and Bifidobacterium abundance alone ( P =0.012). Conclusions: Dysbiosis of intestinal microbiota with variable degree of reduction in Bifidobacterium abundance exhibits promising performance in predicting in-hospital mortality, and provides incremental prognostic value to existing scoring systems in the adult intensive care unit (ICU) setting.